Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-03-02

Clinical Trial Update: Insulin Resistance and Insulin Secretion [NA]

View source ↗

Summary

A clinical trial investigating insulin resistance and insulin secretion in Type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Type 2 | NA | Status: WITHDRAWN